Prestige Biologics Co Ltd
334970
Company Profile
Business description
Prestige Biologics Co Ltd is a CDMO-dedicated company that provides solutions of development and manufacturing tasks throughout the stages from the research/development, engineering, clinical production, commercial production, clinical support, and IND & BLA filing of biopharmaceutical products. Its product candidate includes HD201 (Herceptin Biosimilar).
Contact
197, Osongsaengmyeong 1-ro
Osong-eup, Heungdeok-gu
Chungcheongbuk-do
Cheongju-si28161
KORT: +82 432321552
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2026
Employees
279
Stocks News & Analysis
stocks
Going into earnings, is Microsoft stock a buy, a sell, or fairly valued?
With recent structural changes and strong Azure performance, here’s what we think of Microsoft stock.
stocks
Tesla earnings: Shares fall as market focuses on uncertainty in near term
Are shares overpriced despite the fall?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,317.20 | 26.50 | -0.28% |
| CAC 40 | 8,202.78 | 23.00 | -0.28% |
| DAX 40 | 24,240.28 | 32.49 | 0.13% |
| Dow JONES (US) | 47,152.75 | 418.14 | 0.89% |
| FTSE 100 | 9,610.19 | 31.62 | 0.33% |
| HKSE | 26,160.15 | 192.17 | 0.74% |
| NASDAQ | 23,200.24 | 258.45 | 1.13% |
| Nikkei 225 | 49,299.65 | 658.04 | 1.35% |
| NZX 50 Index | 13,391.59 | 14.49 | 0.11% |
| S&P 500 | 6,795.03 | 56.59 | 0.84% |
| S&P/ASX 200 | 9,019.00 | 25.20 | -0.28% |
| SSE Composite Index | 3,950.31 | 27.90 | 0.71% |